briquilimab
briquilimab: sourced relationships with 1 company · 4 clinical trials tracked.
briquilimab evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
How could briquilimab → JSPR affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Jasper Therapeutics Inc. (JSPR) Chronic Inducible Urticaria; Chronic Spontaneous Urticaria; … | Phase 2 |
Clinical Trial Registry Records (4)
A Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
Primary endpoint: To evaluate the safety and tolerability of briquilimab in mild-to-moderate asthmatic participants
Open-Label Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Chronic Urticaria
Primary endpoint: To evaluate the safety and tolerability of briquilimab
A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Primary endpoint: Incidence and severity of treatment emergent AEs/SAEs [safety and tolerability] of a single dose of briquilimab in patients with ColdU or SD who remain symptomatic despite the use of H1 antihistamines.
A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines and/or Omalizumab, or Who Cannot Tolerate Omalizumab
Primary endpoint: Evaluate the safety and tolerability of briquilimab
Frequently asked questions
Which companies have sourced relationships with briquilimab?
briquilimab has dated SEC/FDA relationship records for Jasper Therapeutics Inc..
How many clinical trials involve briquilimab?
BioSniper tracks 4 clinical trials involving briquilimab.